Lucid Pharma LLC recalls Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and…
- Recall date
- June 1, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0921-2017
- FDA classification
- Class II
- Brand / firm
- Lucid Pharma LLC
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.
Get recall alerts
Free email alert whenever Lucid Pharma LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Lucid Pharma LLC